H Lundbeck B (0ND5)

London
Currency in DKK
Disclaimer
31.81
-141.91
(-81.69%)
Closed
Unusual trading volume
Day's Range
31.81
31.81
52 wk Range
23.36
174.50
Volume
166,728
Prev. Close
173.73
Open
170.65
Day's Range
31.81-31.81
52 wk Range
23.36-174.5
Volume
166,728
Average Volume (3m)
40,715
1-Year Change
-79.45%
Shares Outstanding
992,839,710
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
33.71
Upside +6.07%

People Also Watch

2.520
SNC
0.00%
13.68
SEM
-1.16%
0.1715
IMPA
-1.72%
81.55
COFB
-0.55%

H Lundbeck B Company Profile

H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. The Company operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.

Employees
5452
Market
Denmark